Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Discover Oncology|July 11, 2025
Molecular classification and construction of the risk signature for diffuse large B-cell lymphoma based on vitamin B6 metabolismWen Wei, Dao Xin, Huawei Weng, et al.
Journal of Hematology & Oncology|December 5, 2024
Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO CongressHuageng Huang, Le Yu, Huawei Weng, et al.
Frontiers in Nutrition|July 11, 2025
Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphomaRenqin Li, Wei Zhang, Le Yu, et al.
Annals of Hematology|June 26, 2024
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in ChinaHuawei Weng, Le Yu, Zegeng Chen, et al.
Frontiers in Immunology|August 25, 2023
Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year periodHuageng Huang, Yuyi Yao, Xinyi Deng, et al.
Annals of Hematology|October 20, 2025
A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphomaJingjing Ge, Zegeng Chen, Qunli Xiong, et al.
Radiation Oncology (London, England)|January 21, 2023
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysisYuyi Yao, Xuesong Sun, Huageng Huang, et al.
Genome Medicine|April 2, 2024
Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progressionZegeng Chen, He Huang, Huangming Hong, et al.
Oral Oncology|December 8, 2023
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trialsHuageng Huang, Zegeng Chen, Manyi Zhu, et al.
International Journal of Biological Macromolecules|December 14, 2025
Tumor microenvironment-responsive nanoparticles composed of hyaluronic acid and stearic acid for the treatment of lung metastasis in triple-negative breast cancerFei Pan, Mu Yang, Shichuan Zhang, et al.
Pageof 2